Corbus Pharmaceuticals Holdings, Inc.
CRBPBiotechnology
$4.22−0.71%As of Oct 29vs prior close
- Market cap
- $81.6M
- P/E (TTM)
- –
- From 52W high
- −74.97%
- EPS (LTM)
- -$6.11
- Revenue (YE22)
- $0
- Dividend yield
- 0.00%
Nomior Score
21
Steady ProfileBottom 8% of the scored universe
Growth61
Quality36
Value17
Momentum19
Resilience38
Growth
$0revenue, YE22
YE16 $1.9MYE22 $0
Connections
Revenue to profitYE21
The operating loss was 6350% of revenue, wider by 3231 pts on a year.
Who owns it
2funds